Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer
- 17.06.2023
- Review
- Verfasst von
- Senbang Yao
- Qianqian Zhang
- Xinxin Yao
- Xiuqing Zhang
- Lulian Pang
- Sheng Yu
- Huaidong Cheng
- Erschienen in
- Breast Cancer Research and Treatment | Ausgabe 1/2023
Abstract
Background
Chemotherapy related cognitive impairment (CRCI) has seriously affected the quality of life (QOL) of patients with breast cancer (BCs), thus the neurobiological mechanism of CRCI attracted widespread attention. Previous studies have found that chemotherapy causes CRCI through affecting brain structure, function, metabolism, and blood perfusion.
Findings
A variety of neuroimaging techniques such as functional magnetic resonance imaging (fMRI), event-related potential (ERP), near-infrared spectroscopy (NIRS) have been widely applied to explore the neurobiological mechanism of CRCI.
Conclusion
This review summarized the progress of neuroimaging research in BCs with CRCI, which provides a theoretical basis for further exploration of CRCI mechanism, disease diagnosis and symptom intervention in the future.
Anzeige
- Titel
- Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer
- Verfasst von
-
Senbang Yao
Qianqian Zhang
Xinxin Yao
Xiuqing Zhang
Lulian Pang
Sheng Yu
Huaidong Cheng
- Publikationsdatum
- 17.06.2023
- Verlag
- Springer US
- Erschienen in
-
Breast Cancer Research and Treatment / Ausgabe 1/2023
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217 - DOI
- https://doi.org/10.1007/s10549-023-07005-y
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.